Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated just now
Peer-reviewedCC BYFrontiers in pharmacology

Berberine and celecoxib synergistically suppress non-small cell lung cancer with EGFR/AKT/COX-2-related signaling: network pharmacology, molecular docking and experimental validation

  • Qiang Wang1
  • Chengyu Bian2
  • Xinyuan She3
  • Haonan Du4
  • Minhe Wang5
  • Yu Zheng3
  • Lei Cao6
  • Chenghao Fu5
  • Yuheng Wang7
7 affiliations
  1. 1Department of Thoracic Surgery, Taizhou Fourth People’s Hospital , , ,
  2. 2Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , ,
  3. 3Department of Pathology, Jiangsu Province (Suqian) Hospital , , ,
  4. 4Department of Thoracic Surgery, The First Affiliated Hospital of Xi’an Jiaotong University , , ,
  5. 5Department of Thoracic Surgery, Jiangsu Province People’s Hospital and The First Affiliated Hospital of Nanjing Medical University , , ,
  6. 6Department of Oncology, Jiangsu Province (Suqian) Hospital , , ,
  7. 7Department of Thoracic Surgery, Suzhou Municipal Hospital and The Affiliated Suzhou Hospital of Nanjing Medical University , , ,
Read full textPDFCite

Related

  1. Yaobitong plus celecoxib for low back pain: a Chinese multicenter cohort and network pharmacology study
    Huahui Gong, Chenxing Lu, Zhanghao Guo +6
    Frontiers in pain research (Lausanne, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Network Pharmacology of Natural Products from Computational Prediction to Experimental Validation
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Dihydroartemisinin alleviates allergic airway inflammation by suppressing the PI3K-AKT signaling axis: integrated network pharmacology and experimental validation.
    Suidong Ouyang, Daichi Chen, Hangyu Li +6
    Respiratory researchPeer-reviewedCC BYFull textPhysiologyEurope PMCPMC
  4. Unraveling the multitarget mechanisms of aloe emodin against periodontitis: a synergy of network pharmacology and experimental validation
    Yifan Zhang, Huijing Ma, Shengxiang Zhang +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMC
  5. Renoprotective effects of dapagliflozin and montelukast for diclofenac induced acute kidney injury through network pharmacology and experimental validation
    Nada S. Kamal, Omnia A. Nour, Manar A. Nader
    Scientific ReportsPeer-reviewedCC BY 4.0Full textGeneral medicineCrossref

Cite

BibTeXRIS
BibTeX
@article{wang2026berberine,
  title = {{Berberine and celecoxib synergistically suppress non-small cell lung cancer with EGFR/AKT/COX-2-related signaling: network pharmacology, molecular docking and experimental validation}},
  author = {Qiang Wang and Chengyu Bian and Xinyuan She and Haonan Du and Minhe Wang and Yu Zheng and Lei Cao and Chenghao Fu and Yuheng Wang},
  journal = {Frontiers in pharmacology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658603},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Berberine and celecoxib synergistically suppress non-small cell lung cancer with EGFR/AKT/COX-2-related signaling: network pharmacology, molecular docking and experimental validation
AU  - Qiang Wang
AU  - Chengyu Bian
AU  - Xinyuan She
AU  - Haonan Du
AU  - Minhe Wang
AU  - Yu Zheng
AU  - Lei Cao
AU  - Chenghao Fu
AU  - Yuheng Wang
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in pharmacology
UR  - https://europepmc.org/article/PMC/PMC13658603
SN  - 1663-9812
ER  -